{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T05:39:16Z","timestamp":1780637956655,"version":"3.54.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T00:00:00Z","timestamp":1745798400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T00:00:00Z","timestamp":1745798400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiologie"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1007\/s00117-025-01447-9","type":"journal-article","created":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T18:05:55Z","timestamp":1745863555000},"page":"500-507","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Bildgebende Prim\u00e4rdiagnostik bei Lymphomen","Primary imaging diagnostics of lymphomas"],"prefix":"10.1007","volume":"65","author":[{"given":"Michael","family":"Winkelmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Kassube","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"R\u00fcbenthaler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel T.","family":"Sheikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang G.","family":"Kunz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,28]]},"reference":[{"key":"1447_CR1","doi-asserted-by":"publisher","first-page":"3059","DOI":"10.1200\/JCO.2013.54.8800","volume":"32","author":"BD Cheson","year":"2014","unstructured":"Cheson\u00a0BD, Fisher\u00a0RI, Barrington\u00a0SF et\u00a0al (2014) Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: The Lugano classification. J\u00a0Clin Oncol 32:3059\u20133068","journal-title":"J Clin Oncol"},{"key":"1447_CR2","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1007\/s11864-016-0399-z","volume":"17","author":"G Thanarajasingam","year":"2016","unstructured":"Thanarajasingam\u00a0G, Bennani-Baiti\u00a0N, Thompson\u00a0CA (2016) PET-CT in Staging, Response Evaluation, and Surveillance of Lymphoma. Curr Treat Options Oncol 17:24","journal-title":"Curr Treat Options Oncol"},{"key":"1447_CR3","doi-asserted-by":"crossref","unstructured":"Leithner D, Neri E, D\u2019anastasi M et\u00a0al (2025) ESR Essentials: imaging of lymphoma-practice recommendations by the European Society of Oncologic Imaging. Eur Radiol","DOI":"10.1007\/s00330-024-11213-5"},{"key":"1447_CR4","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1097\/RLU.0000000000003404","volume":"46","author":"AM Starzer","year":"2021","unstructured":"Starzer\u00a0AM, Berghoff\u00a0AS, Traub-Weidinger\u00a0T et\u00a0al (2021) Assessment of Central Nervous System Lymphoma Based on CXCR4 Expression In Vivo Using 68Ga-Pentixafor PET\/MRI. Clin Nucl Med 46:16\u201320","journal-title":"Clin Nucl Med"},{"key":"1447_CR5","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1093\/neuonc\/noab020","volume":"23","author":"RF Barajas","year":"2021","unstructured":"Barajas\u00a0RF, Politi\u00a0LS, Anzalone\u00a0N et\u00a0al (2021) Consensus recommendations for MRI and PET imaging of primary central nervous system lymphoma: guideline statement from the International Primary CNS Lymphoma Collaborative Group (IPCG). Neuro Oncol 23:1056\u20131071","journal-title":"Neuro Oncol"},{"key":"1447_CR6","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1148\/radiol.11101821","volume":"263","author":"HC Thoeny","year":"2012","unstructured":"Thoeny\u00a0HC, De Keyzer\u00a0F, King\u00a0AD (2012) Diffusion-weighted MR imaging in the head and neck. Radiology 263:19\u201332","journal-title":"Radiology"},{"key":"1447_CR7","first-page":"1079","volume":"27","author":"JW Choi","year":"2006","unstructured":"Choi\u00a0JW, Kim\u00a0SS, Kim\u00a0EY et\u00a0al (2006) Peripheral T\u2011cell lymphoma in the neck: CT findings of lymph node involvement. Ajnr Am J Neuroradiol 27:1079\u20131082","journal-title":"Ajnr Am J Neuroradiol"},{"key":"1447_CR8","doi-asserted-by":"publisher","first-page":"102","DOI":"10.2967\/jnumed.122.264106","volume":"64","author":"F Ricard","year":"2023","unstructured":"Ricard\u00a0F, Cheson\u00a0B, Barrington\u00a0S et\u00a0al (2023) Application of the Lugano Classification for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The PRoLoG Consensus Initiative (Part\u00a01-Clinical). J\u00a0Nucl Med 64:102\u2013108","journal-title":"J Nucl Med"},{"key":"1447_CR9","unstructured":"Mikhaeel NG, Heymans MW, Eertink JJ et\u00a0al Proposed New Dynamic Prognostic Index for Diffuse Large B\u2011Cell Lymphoma: International Metabolic Prognostic Index. J\u00a0Clin Oncol 202(2):JCO2102063"},{"key":"1447_CR10","doi-asserted-by":"crossref","unstructured":"Winkelmann M, Blumenberg V, Rejeski K et\u00a0al (2022) Prognostic value of the International Metabolic Prognostic Index for lymphoma patients receiving chimeric antigen receptor T\u2011cell therapy. Eur J Nucl Med Mol Imaging","DOI":"10.1007\/s00259-022-06075-2"},{"key":"1447_CR11","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.2967\/jnumed.121.262205","volume":"63","author":"CN Burggraaff","year":"2022","unstructured":"Burggraaff\u00a0CN, Eertink\u00a0JJ, Lugtenburg\u00a0PJ et\u00a0al (2022) (18)F-FDG PET Improves Baseline Clinical Predictors of Response in Diffuse Large B\u2011Cell Lymphoma: The HOVON-84 Study. J\u00a0Nucl Med 63:1001\u20131007","journal-title":"J Nucl Med"},{"key":"1447_CR12","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1093\/annonc\/mdy250","volume":"29","author":"CA Voltin","year":"2018","unstructured":"Voltin\u00a0CA, Goergen\u00a0H, Baues\u00a0C et\u00a0al (2018) Value of bone marrow biopsy in Hodgkin lymphoma patients staged by FDG PET: results from the German Hodgkin Study Group trials HD16, HD17, and HD18. Ann Oncol 29:1926\u20131931","journal-title":"Ann Oncol"},{"issue":"iv19","key":"1447_CR13","first-page":"iv29","volume":"29","author":"DA Eichenauer","year":"2018","unstructured":"Eichenauer\u00a0DA, Aleman\u00a0BMP, Andre\u00a0M et\u00a0al (2018) Hodgkin lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 29(iv19):iv29","journal-title":"Ann Oncol"},{"key":"1447_CR14","doi-asserted-by":"publisher","first-page":"3150","DOI":"10.1200\/JCO.2015.65.6520","volume":"34","author":"N Schmitz","year":"2016","unstructured":"Schmitz\u00a0N, Zeynalova\u00a0S, Nickelsen\u00a0M et\u00a0al (2016) CNS International Prognostic Index: A\u00a0Risk Model for CNS Relapse in Patients With Diffuse Large B\u2011Cell Lymphoma Treated With R\u2011CHOP. J\u00a0Clin Oncol 34:3150\u20133156","journal-title":"J Clin Oncol"},{"key":"1447_CR15","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1182\/blood-2003-12-4434","volume":"104","author":"P Solal-Celigny","year":"2004","unstructured":"Solal-Celigny\u00a0P, Roy\u00a0P, Colombat\u00a0P et\u00a0al (2004) Follicular lymphoma international prognostic index. Blood 104:1258\u20131265","journal-title":"Blood"},{"key":"1447_CR16","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1182\/blood-2007-06-095331","volume":"111","author":"E Hoster","year":"2008","unstructured":"Hoster\u00a0E, Dreyling\u00a0M, Klapper\u00a0W et\u00a0al (2008) A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma. Blood 111:558\u2013565","journal-title":"Blood"},{"key":"1447_CR17","doi-asserted-by":"publisher","first-page":"W105","DOI":"10.2214\/AJR.09.4105","volume":"195","author":"D Hayashi","year":"2010","unstructured":"Hayashi\u00a0D, Devenney-Cakir\u00a0B, Lee\u00a0JC et\u00a0al (2010) Mucosa-associated lymphoid tissue lymphoma: multimodality imaging and histopathologic correlation. AJR Am J Roentgenol 195:W105\u2013117","journal-title":"AJR Am J Roentgenol"},{"key":"1447_CR18","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1093\/annonc\/mdt343","volume":"6","author":"E Zucca","year":"2013","unstructured":"Zucca\u00a0E, Copie-Bergman\u00a0C, Ricardi\u00a0U et\u00a0al (2013) Gastric marginal zone lymphoma of MALT type: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 6:144\u2013148","journal-title":"Ann Oncol"},{"key":"1447_CR19","doi-asserted-by":"publisher","first-page":"8657","DOI":"10.1038\/s41598-019-45144-9","volume":"9","author":"W Deng","year":"2019","unstructured":"Deng\u00a0W, Wan\u00a0Y, Yu\u00a0JQ (2019) Pulmonary MALT Lymphoma has variable features on CT. Sci Rep 9:8657","journal-title":"Sci Rep"},{"key":"1447_CR20","series-title":"on","volume-title":"Sarcoid-Like Reaction in Non-Hodgkin\u2019s Lymphoma\u2014A Diagnostic Challenge for Deauville Scoring","author":"M Winkelmann","year":"2021","unstructured":"Winkelmann\u00a0M, Rejeski\u00a0K, Subklewe\u00a0M et\u00a0al (2021) Sarcoid-Like Reaction in Non-Hodgkin\u2019s Lymphoma\u2014A Diagnostic Challenge for Deauville Scoring. on, Bd. 18. F\u2011FDG PET\/CT Imaging. Diagnostics (Basel)"},{"key":"1447_CR21","first-page":"950","volume":"47","author":"HA Jacene","year":"2006","unstructured":"Jacene\u00a0HA, Ishimori\u00a0T, Engles\u00a0JM et\u00a0al (2006) Effects of pegfilgrastim on normal biodistribution of 18F-FDG: preclinical and clinical studies. J\u00a0Nucl Med 47:950\u2013956","journal-title":"J Nucl Med"},{"key":"1447_CR22","doi-asserted-by":"crossref","unstructured":"Wilpert C, Wenkel E, Pa BT et\u00a0al (2024) Vaccine-associated axillary lymphadenopathy with a\u00a0focus on COVID-19 vaccines. Rofo","DOI":"10.1055\/a-2328-7536"},{"key":"1447_CR23","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1097\/MNM.0000000000000697","volume":"38","author":"J Dubreuil","year":"2017","unstructured":"Dubreuil\u00a0J, Salles\u00a0G, Bozzetto\u00a0J et\u00a0al (2017) Usual and unusual pitfalls of 18F-FDG-PET\/CT in lymphoma after treatment: a\u00a0pictorial review. Nucl Med Commun 38:563\u2013576","journal-title":"Nucl Med Commun"},{"key":"1447_CR24","doi-asserted-by":"publisher","first-page":"3915","DOI":"10.1007\/s00330-020-06732-w","volume":"30","author":"S Kharuzhyk","year":"2020","unstructured":"Kharuzhyk\u00a0S, Zhavrid\u00a0E, Dziuban\u00a0A et\u00a0al (2020) Comparison of whole-body MRI with diffusion-weighted imaging and PET\/CT in lymphoma staging. Eur Radiol 30:3915\u20133923","journal-title":"Eur Radiol"},{"key":"1447_CR25","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1007\/s00277-021-04537-5","volume":"100","author":"M Picardi","year":"2021","unstructured":"Picardi\u00a0M, Cavaliere\u00a0C, Pepa\u00a0DR et\u00a0al (2021) PET\/MRI for staging patients with Hodgkin lymphoma: equivalent results with PET\/CT in a\u00a0prospective trial. Ann Hematol 100:1525\u20131535","journal-title":"Ann Hematol"},{"key":"1447_CR26","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.cpet.2024.05.002","volume":"19","author":"JS Enke","year":"2024","unstructured":"Enke\u00a0JS, Bundschuh\u00a0RA, Claus\u00a0R et\u00a0al (2024) New PET Tracers for Lymphoma. PET Clin 19:463\u2013474","journal-title":"PET Clin"},{"key":"1447_CR27","doi-asserted-by":"publisher","first-page":"567","DOI":"10.7150\/thno.48620","volume":"11","author":"ME Mayerhoefer","year":"2021","unstructured":"Mayerhoefer\u00a0ME, Raderer\u00a0M, Lamm\u00a0W et\u00a0al (2021) CXCR4 PET imaging of mantle cell lymphoma using [(68)Ga]Pentixafor: comparison with [(18)F]FDG-PET. Theranostics 11:567\u2013578","journal-title":"Theranostics"}],"container-title":["Die Radiologie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00117-025-01447-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00117-025-01447-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00117-025-01447-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T12:29:35Z","timestamp":1750940975000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00117-025-01447-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,28]]},"references-count":27,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["1447"],"URL":"https:\/\/doi.org\/10.1007\/s00117-025-01447-9","relation":{},"ISSN":["2731-7048","2731-7056"],"issn-type":[{"value":"2731-7048","type":"print"},{"value":"2731-7056","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,28]]},"assertion":[{"value":"25 March 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"W.G.\u00a0Kunz gibt Advisor bei Bristol Myers Squibb, Boehringer Ingelheim, mintMedical und Need, Inc. an. M.\u00a0Winkelmann, M.\u00a0Kassube, J.\u00a0R\u00fcbenthaler und G.T.\u00a0Sheikh geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}